Han Xiu-jie, Dong Bao-wei, Liang Ping, Yu Xiao-ling, Yu De-jiang
Department of Diagnostic Ultrasonography, Beijing Hospital, Beijing 100730, China.
Zhonghua Zhong Liu Za Zhi. 2009 Aug;31(8):602-6.
To investigate the local cellular immune response after injection of superantigen, the highly agglutinative staphylococin (HAS), into the tumor bed after ultrasound-guided percutaneous microwave coagulation therapy (PMCT) in the liver cancer patients.
Ninety-two patients with pathologically proven primary liver cancer were divided into two groups: 45 in group A were treated by PMCT alone and 47 in the group B by combined with ultrasound-guided percutaneous injection of highly agglutinative staphylococin (HAS). Before and after PMCT and HAS treatment, the patients underwent ultrasound-guided percutaneous biopsy from the tumor bed and the samples were examined by pathology and immunohistochemistry. The infiltration of CD3+, CD4+, CD57+ and CD68+ lymphocytes in treatment zone was compared between the two groups. Moreover, the infiltrating immunocytes were observed by transmission electron microscopy.
One week after HAS injection, the densities of CD3+, CD4+, CD57+ and CD68+ cells in the group B were 54.50 +/- 18.44, 38.14 +/- 12.44, 33.38 +/- 10.79 and 45.56 +/- 16.53, respectively. All the above mentioned parameters increased significantly in varying degrees compared with that before PMCT or HAS injection (P < 0.05). Four weeks after HAS injection, the density of CD3+, CD4+, CD57+ and CD68+ cells in the group B were 32.67 +/- 10.42, 23.43 +/- 6.99, 18.63 +/- 7.89 and 30.01 +/- 11.05, respectively, still significantly higher than those before PMCT (P < 0.05). Five weeks after PMCT and HAS injection, the densities of CD3+, CD4+, CD57+ and CD68+ cells in the group B were 54.50 +/- 18.44, 38.14 +/- 12.44, 33.38 +/- 10.79 and 45.56 +/- 16.53, versus 32.03 +/- 8.11, 15.67 +/- 8.32, 15.23 +/- 8.26 and 29.67 +/- 11.98 in the group A, respectively, still with a significant difference between the two groups (P < 0.05). A lot of lysosomes, endoplasmic reticulum and mitochondria in the immune cells after injection of HAS were observed by transmission electron microscopy.
The local cellular immunity in liver cancer treatment area can be significantly improved by ultrasound-guided injection of highly agglutinative staphylococin after percutaneous microwave coagulation therapy.
探讨在肝癌患者经超声引导下经皮微波凝固治疗(PMCT)后,向肿瘤床注射超抗原——高聚集性葡萄球菌素(HAS)后的局部细胞免疫反应。
92例经病理证实的原发性肝癌患者分为两组:A组45例仅接受PMCT治疗,B组47例接受超声引导下经皮注射高聚集性葡萄球菌素(HAS)联合PMCT治疗。在PMCT和HAS治疗前后,患者接受超声引导下经皮肿瘤床穿刺活检,样本进行病理和免疫组化检查。比较两组治疗区域CD3 +、CD4 +、CD57 +和CD68 +淋巴细胞的浸润情况。此外,通过透射电子显微镜观察浸润的免疫细胞。
注射HAS后1周,B组CD3 +、CD4 +、CD57 +和CD68 +细胞密度分别为54.50±18.44、38.14±12.44、33.38±10.79和45.56±16.53。与PMCT或HAS注射前相比,上述所有参数均有不同程度的显著增加(P < 0.05)。注射HAS后4周,B组CD3 +、CD4 +、CD57 +和CD68 +细胞密度分别为32.67±10.42、23.43±6.99、18.63±7.89和30.01±11.05,仍显著高于PMCT前(P < 0.05)。PMCT和HAS注射后5周,B组CD3 +、CD4 +、CD57 +和CD68 +细胞密度分别为54.50±18.44、38.14±12.44、33.38±10.79和45.56±16.53,A组分别为32.03±8.11、15.67±8.32、15.23±8.26和29.67±11.98,两组仍有显著差异(P < 0.05)。透射电子显微镜观察发现,注射HAS后免疫细胞中有大量溶酶体、内质网和线粒体。
经皮微波凝固治疗后,超声引导下注射高聚集性葡萄球菌素可显著改善肝癌治疗区域的局部细胞免疫。